Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureZiyi Hua, Yongqiang Shu, Shan Xia, Junjian Xiao, Jiangping Li, Ying Ji, Dechang Peng, Ailan Wan, Guojiang Wu
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Maternal obesity alters histone modifications mediated by the interaction between EZH2 and AMPK, impairing neural differentiation in the developing embryonic brain cortex
10.1016/j.jbc.2025.108173 · 2025
Cingulate microstimulation induces negative decision-making via reduced top-down influence on primate fronto-cingulo-striatal network
10.1038/s41467-024-48375-1 · 2024
Pharmacokinetic-Pharmacodynamic Relationship of the Selective Serotonin Reuptake Inhibitors
10.2165/00003088-199631060-00004 · 1996
Scale for suicide ideation: Psychometric properties of a self-report version
10.1002/1097-4679(198807)44:4<499::aid-jclp2270440404>3.0.co;2-6 · 1988
Depression diagnosis: EEG-based cognitive biomarkers and machine learning
10.1016/j.bbr.2024.115325 · 2025
Dopaminergic frontostriatal pathways in major depressive disorder and childhood sexual abuse: a multimodal neuroimaging investigation
10.1038/s41380-025-03218-3 · 2026
Psychomotor retardation in depression: Biological underpinnings, measurement, and treatment
10.1016/j.pnpbp.2010.10.019 · 2011
Neuronal Oscillations in Cortical Networks
10.1126/science.1099745 · 2004
Scoring higher the second time around: Meta-analyses of practice effects in neuropsychological assessment
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
10.1080/13854046.2012.680913 · 2012
Global economic burden of depression in 154 countries from 2025 to 2050
10.1038/s41591-026-04548-7 · 2026
Alteration of whole-brain amplitude of low-frequency fluctuation and degree centrality in patients with mild to moderate depression: A resting-state functional magnetic resonance imaging study
10.3389/fpsyt.2022.1061359 · 2022
Characterizing Typhoon-related Posttraumatic Stress Disorder Based on Multimodal Fusion of Structural, Diffusion, and Functional Magnetic Resonance Imaging
10.1016/j.neuroscience.2023.11.018 · 2024
Emerging strategies and clinical recommendations for the management of novel depression subtypes
10.1080/14737175.2025.2470973 · 2025
Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis
10.1016/s0140-6736(17)32802-7 · 2018
Longitudinal change in performance on the montreal cognitive assessment in older adults
10.1080/13854046.2015.1087596 · 2015
Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression: A Randomized Clinical Trial
10.1001/jamapsychiatry.2017.3739 · 2018
Cognitive decline is associated with frequency-specific resting state functional changes in normal aging
10.1007/s11682-022-00682-1 · 2022
Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
10.1038/s41380-018-0256-5 · 2020
What can neuroimaging of neuromodulation reveal about the basis of circuit therapies for psychiatry?
10.1038/s41386-024-01976-2 · 2025
Decreased resting-state neural signal in the left angular gyrus as a potential neuroimaging biomarker of schizophrenia: An amplitude of low-frequency fluctuation and support vector machine analysis
10.3389/fpsyt.2022.949512 · 2022
RETRACTED: Transcriptional correlates of frequency-dependent brain functional activity associated with symptom severity in degenerative cervical myelopathy
10.1016/j.neuroimage.2023.120451 · 2023
The neurodegenerative hypothesis of depression and the influence of antidepressant medications
10.1016/j.ejphar.2024.176967 · 2024
10.1037/t04100-000
10.1037/t04100-000
Exploring the correlation between frequency-dependent brain activity and cognitive function in social anxiety disorder
10.1016/j.brainresbull.2025.111603 · 2025
Frequency-dependent alterations in functional connectivity in patients with Alzheimer’s Disease spectrum disorders
10.3389/fnagi.2024.1375836 · 2024
Impaired visual-motor functional connectivity in first-episode medication-naïve patients with major depressive disorder
10.1093/cercor/bhad387 · 2024
Effects of esketamine on depression-like behavior and dendritic spine plasticity in the prefrontal cortex neurons of spared nerve injury-induced depressed mice
10.1590/1414-431x2024e13736 · 2024
Amplitude of low-frequency fluctuation (ALFF) alterations in adults with subthreshold depression after physical exercise: A resting-state fMRI study
10.1016/j.jad.2021.08.094 · 2021
Systematic Review and Meta-Analysis: Dose-Response Relationship of Selective Serotonin Reuptake Inhibitors in Major Depressive Disorder
10.1176/appi.ajp.2015.15030331 · 2016
The effects of ketamine and esketamine on functional outcomes in major depressive disorder and treatment-resistant depression: A systematic review
10.1016/j.jpsychires.2025.10.056 · 2026
Esketamine alleviates depressive-like behavior in neuropathic pain mice through the METTL3-GluA1 pathway
10.1007/s10565-024-09975-1 · 2025
Local brain abnormalities in emotional disorders: Evidence from resting state fMRI studies
10.1002/wcs.1694 · 2024
The N -methyl- d -aspartate receptor hypothesis of ketamine’s antidepressant action: evidence and controversies
10.1098/rstb.2023.0225 · 2024
Ketamine in neuropsychiatric disorders: an update
10.1038/s41386-023-01632-1 · 2024
Exploring Esketamine’s Therapeutic Outcomes as an FDA-Designated Breakthrough for Treatment-Resistant Depression and Major Depressive Disorder With Suicidal Intent: A Narrative Review
2024
Novel rapid treatment options for adolescent depression
10.1016/j.phrs.2024.107085 · 2024
Large‐scale dynamic causal modeling of major depressive disorder based on resting‐state functional magnetic resonance imaging
10.1002/hbm.24845 · 2020
Effects of esketamine on electrophysiology and metabolic reprogramming in brain organoids: insights into antidepressant mechanisms
10.1038/s41380-025-03198-4 · 2025
Changes in the amplitude of low-frequency fluctuations in specific frequency bands in major depressive disorder after electroconvulsive therapy
10.5498/wjp.v12.i5.708 · 2022
Structural neural plasticity evoked by rapid-acting antidepressant interventions
10.1038/s41583-024-00876-0 · 2025
The oscillating brain: Complex and reliable
10.1016/j.neuroimage.2009.09.037 · doi-reference
An improved approach to detection of amplitude of low-frequency fluctuation (ALFF) for resting-state fMRI: Fractional ALFF
10.1016/j.jneumeth.2008.04.012 · doi-reference
Transcriptomic decoding of regional cortical vulnerability to major depressive disorder
10.1038/s42003-024-06665-w · doi-reference
Distinctive intrinsic functional connectivity alterations of anterior cingulate cortex subdivisions in major depressive disorder: A systematic review and meta-analysis
10.1016/j.neubiorev.2024.105583 · doi-reference
Amplitude of brain low-frequency fluctuation and functional connectivity changes based on fMRI study in first-episode major depressive disorder
10.1016/j.clineuro.2025.109157 · doi-reference
Change in the global burden of depression from 1990-2019 and its prediction for 2030
10.1016/j.jpsychires.2024.07.054 · doi-reference
Amplitude of Low-Frequency Oscillations in First-Episode Drug-Naive Patients with Major Depressive Disorder: A Resting State Functional Magnetic Resonance Imaging Study
10.2147/ndt.s348683 · doi-reference
A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression
10.1001/archpsyc.63.8.856 · doi-reference
Altered baseline brain activity in children with ADHD revealed by resting-state functional MRI
10.1016/j.braindev.2006.07.002 · doi-reference
Altered Spontaneous Brain Activity Patterns in Patients After Lasik Surgery Using Amplitude of Low-Frequency Fluctuation: A Resting-State Functional MRI Study
10.2147/ndt.s252850 · doi-reference
Effects of subanesthetic repeated esketamine infusions on memory function and NGF in patients with depression: An open-label study
10.1016/j.jad.2024.09.162 · doi-reference
Frequency‐specific coactivation patterns in resting‐state and their alterations in schizophrenia: An fMRI study
10.1002/hbm.25884 · doi-reference
DPABI: Data Processing & Analysis for (Resting-State) Brain Imaging
10.1007/s12021-016-9299-4 · doi-reference
Global, regional, and national incidence trends of depressive disorder, 1990–2019: An age-period-cohort analysis based on the Global Burden of Disease 2019 study
10.1016/j.genhosppsych.2024.03.003 · doi-reference
The Pathogenesis and Medical Treatment of Depression: Opportunity and Challenge
10.3390/neurolint17080120 · doi-reference
A neuroimaging-based precision medicine framework for depression
10.1016/j.ajp.2023.103803 · doi-reference
A Comprehensive Overview of the Role of Visual Cortex Malfunction in Depressive Disorders: Opportunities and Challenges
10.1007/s12264-023-01052-7 · doi-reference
Serotonin is a common thread linking different classes of antidepressants
10.1016/j.chembiol.2023.10.009 · doi-reference
Abnormal functional connectivity within the prefrontal cortex is associated with multiple plasma lipid species in major depressive disorder
10.1016/j.jad.2023.12.072 · doi-reference
Longitudinal changes of amplitude of low-frequency fluctuations in MDD patients: A 6-month follow-up resting-state functional magnetic resonance imaging study
10.1016/j.jad.2020.07.067 · doi-reference
Structural brain alterations associated with suicidal thoughts and behaviors in young people: results from 21 international studies from the ENIGMA Suicidal Thoughts and Behaviours consortium
10.1038/s41380-022-01734-0 · doi-reference
The role of frontal EEG in predicting clinical response of major depressive disorder to intranasal ketamine and esketamine
10.1016/j.jad.2025.120751 · doi-reference
Alterations in Cerebral Intrinsic Activity in First-Episode, Drug-Naive Patients With Major Depressive Disorder
10.7759/cureus.83737 · doi-reference
Modulation of habenular and nucleus accumbens functional connectivity by ketamine in major depression
10.1002/brb3.3511 · doi-reference
Prefrontal neurophysiological changes associated with subanesthetic esketamine accelerating mice emergence from propofol anesthesia
10.1016/j.brainresbull.2025.111648 · doi-reference
Metabolomics in Depression: What We Learn from Preclinical and Clinical Evidences
10.1007/s12035-024-04302-5 · doi-reference
A schizophrenia study based on multi-frequency dynamic functional connectivity analysis of fMRI
10.3389/fnhum.2023.1164685 · doi-reference
Aberrant Neural Activity in Patients With Bipolar Depressive Disorder Distinguishing to the Unipolar Depressive Disorder: A Resting-State Functional Magnetic Resonance Imaging Study
10.3389/fpsyt.2018.00238 · doi-reference
Differential brain activity in patients with disorders of consciousness: a 3-month rs-fMRI study using amplitude of low-frequency fluctuation
10.3389/fneur.2024.1477596 · doi-reference
Surface-based functional brain imaging analysis of major depressive disorder after electroconvulsive therapy
10.1016/j.jad.2025.119492 · doi-reference
Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy
10.1007/s40262-016-0383-6 · doi-reference
Exploring the role of inflammation in major depressive disorder: beyond the monoamine hypothesis
10.3389/fnbeh.2023.1282242 · doi-reference
The role of histone modifications: from neurodevelopment to neurodiseases
10.1038/s41392-022-01078-9 · doi-reference
Validation of the Chinese version of Addenbrooke’s cognitive examination III for detecting mild cognitive impairment
10.1080/13607863.2021.1881757 · doi-reference
Age exacerbates the negative effect of depression on executive functioning in racial and ethnic minorities
10.1007/s11682-024-00898-3 · doi-reference
Amplitude of low‐frequency fluctuations on Alzheimer’s disease with depression: evidence from resting‐state fMRI
10.1136/gpsych-2019-100147 · doi-reference
Characterizing, Assessing, and Treating Cognitive Dysfunction in Major Depressive Disorder
10.1097/hrp.0000000000000171 · doi-reference
Abnormal amygdala functional connectivity and deep learning classification in multifrequency bands in autism spectrum disorder: A multisite functional magnetic resonance imaging study
10.1002/hbm.26141 · doi-reference
The power of many brains: Catalyzing neuropsychiatric discovery through open neuroimaging data and large-scale collaboration
10.1016/j.scib.2024.03.006 · doi-reference
The altered multiscale dynamics of spontaneous brain activity in depression with Parkinson’s disease
10.1007/s10072-022-05974-4 · doi-reference